DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Nephros, Inc. – Linkedin
Nephros is a commercial stage medical device company that develops and sells high-performance liquid purification filters. Nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins.
Nephros was founded in 1997, by healthcare professionals affiliated with Columbia University Medical Center, initially to address the needs of chronic renal failure patients. The company has developed an alternative to current hemodialysis therapy known as Mid-dilution hemodiafiltration (mid-HDF). Nephros’ proprietary blood purification technologies enable mid-HDF to be offered to chronic renal failure patients. Nephros mid-dilution filters remove a range of harmful substances, specifically substances known as middle molecules, which have been linked to conditions such as carpal tunnel syndrome, dialysis-related amyloidosis, and degenerative bone disease in chronic renal failure patients.
Related Content
-
people & placesInternational Myeloma FoundationThe International Myeloma Foundation (IM...
-
news & meetingsRare Disease Day at NIH 2023Rare Disease Day® takes place worldwide...
-
people & placesRahma Warsame, MDDr. Rahma Warsame is an Associate Profes...
-
people & placesCarlos Heras-PalouCarlos Heras-Palou qualified from the ...
-
videos & visualsIntellia CRISPR CAS9 Update – ASG Webinar 11/11https://www.youtube.com/watch?v=K2TmwAfu...
-
news & meetingsWebinar Event on Progress in Amyloidosis Research: Where Are We Now?Join a Live Webinar Event on “Prog...
-
people & placesFrançoise PelcotFrançoise Pelcot is the Director of Ass...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.